{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:11:57Z","timestamp":1790104317087,"version":"4.0.1"},"reference-count":122,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan","award":["AP19678934"],"award-info":[{"award-number":["AP19678934"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Inflammation is a self-defense mechanism that controls the homeostasis of an organism, and its alteration by persistent noxious stimuli could lead to an imbalance in the regulation of inflammatory responses mediated by innate and adaptive immunity. During chronic inflammation, sustained exposure of myeloid cells to the various inflammatory signals derived from inflamed tissue could lead to the generation of myeloid cells with an immunosuppressive state, called myeloid-derived suppressor cells (MDSCs), which can exert protective or deleterious functions depending on the nature of signals and the specific inflammatory conditions created by different pathophysiological contexts. Initially identified in various tumor models and cancer patient samples, these cells have long been recognized as negative regulators of anti-tumor immunity. Consequently, researchers have focused on elucidating the molecular mechanisms underlying their potent immunosuppressive activity. As a key component of the signal transducing processes, protein kinases play a central role in regulating the signal transduction mechanisms of many cellular activities, including differentiation and immunosuppression. Over the past decade, at least a dozen kinases, including mechanistic target of rapamycin (mTOR), phosphoinositide 3-kinases (PI3Ks), TAM (Tyro3, Axl, Mer) family of receptor tyrosine kinases (TAM RTKs), mitogen-activated protein kinases (MAPKs), and others, have emerged as key contributors to the generation and differentiation of MDSCs. Here, we discuss the recent findings on these kinases that directly contribute to the immunosuppressive functions of MDSCs.<\/jats:p>","DOI":"10.3390\/ijms26146936","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T09:33:53Z","timestamp":1753090433000},"page":"6936","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Protein Kinases in the Suppressive Phenotype of Myeloid-Derived Suppressor Cells"],"prefix":"10.3390","volume":"26","author":[{"given":"Aikyn","family":"Kali","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Immunology and Immunobiotechnology, M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurshat","family":"Abdolla","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology and Immunobiotechnology, M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, Kazakhstan"},{"name":"Almaty Branch of the National Center for Biotechnology, Almaty 050054, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya V.","family":"Perfilyeva","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology and Immunobiotechnology, M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, Kazakhstan"},{"name":"Almaty Branch of the National Center for Biotechnology, Almaty 050054, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3771-423X","authenticated-orcid":false,"given":"Yekaterina O.","family":"Ostapchuk","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology and Immunobiotechnology, M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, Kazakhstan"},{"name":"Almaty Branch of the National Center for Biotechnology, Almaty 050054, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raikhan","family":"Tleulieva","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology and Immunobiotechnology, M.A. Aitkhozhin Institute of Molecular Biology and Biochemistry, Almaty 050012, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4049\/jimmunol.1701069","article-title":"Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5","volume":"201","author":"Wang","year":"2018","journal-title":"J. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/eji.201948240","article-title":"Human Monocytic Myeloid-Derived Suppressor Cells Impair B-Cell Phenotype and Function in Vitro","volume":"50","author":"Jaufmann","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Yang, Y., Li, C., Liu, T., Dai, X., and Bazhin, A.V. (2020). Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01371"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4049\/jimmunol.1900500","article-title":"Functional Diversity of Myeloid-Derived Suppressor Cells: The Multitasking Hydra of Cancer","volume":"203","author":"Jayakumar","year":"2019","journal-title":"J. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"\u00d6zkan, B., Lim, H., and Park, S.G. (2018). Immunomodulatory Function of Myeloid-Derived Suppressor Cells during B Cell-Mediated Immune Responses. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051468"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.179.2.977","article-title":"Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response","volume":"179","author":"Sinha","year":"2007","journal-title":"J. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/onc.2014.143","article-title":"Activation of MTOR Pathway in Myeloid-Derived Suppressor Cells Stimulates Cancer Cell Proliferation and Metastasis in Lal-\/- Mice","volume":"34","author":"Zhao","year":"2014","journal-title":"Oncogene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1172\/JCI99673","article-title":"\u0394np63-Driven Recruitment of Myeloid-Derived Suppressor Cells Promotes Metastasis in Triple-Negative Breast Cancer","volume":"128","author":"Kumar","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wang, Y., Ding, Y., Guo, N., and Wang, S. (2019). MDSCs: Key Criminals of Tumor Pre-Metastatic Niche Formation. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00172"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3892\/or.2021.7936","article-title":"Critical Immunosuppressive Effect of MDSC-Derived Exosomes in the Tumor Microenvironment","volume":"45","author":"Rashid","year":"2021","journal-title":"Oncol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1158\/0008-5472.CAN-24-1241","article-title":"Circulating Tumor Microenvironment in Metastasis","volume":"85","author":"Tang","year":"2025","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for Myeloid-Derived Suppressor Cell Nomenclature and Characterization Standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-Derived Suppressor Cells in Cancer and Cancer Therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: Markers, Development, States, and Unaddressed Complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3892\/or.2016.5291","article-title":"Immature Myeloid-Derived Suppressor Cells: A Bridge between Inflammation and Cancer (Review)","volume":"37","author":"Musolino","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zhu, Y., and Cao, S. (2025). Unraveling the Complexities of Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26073291"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.18632\/oncotarget.12278","article-title":"On the Origin of Myeloid-Derived Suppressor Cells","volume":"8","author":"Millrud","year":"2016","journal-title":"Oncotarget"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wu, X., Zhu, D., Tian, J., Tang, X., Guo, H., Ma, J., Xu, H., and Wang, S. (2020). Granulocytic Myeloid-Derived Suppressor Cell Exosomal Prostaglandin E2 Ameliorates Collagen-Induced Arthritis by Enhancing IL-10+ B Cells. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.588500"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3892\/etm.2016.4018","article-title":"Myeloid-Derived Suppressor Cells and Myeloid Regulatory Cells in Cancer and Autoimmune Disorders (Review)","volume":"13","author":"Barnie","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lee, J.Y., Sohn, H.J., Kim, C.H., Kim, T.G., and Lee, H.S. (2022). Local and Systemic Injections of Human Cord Blood Myeloid-Derived Suppressor Cells to Prevent Graft Rejection in Corneal Transplantation. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123223"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1586\/1744666X.2014.948424","article-title":"The Roles of Myeloid-Derived Suppressor Cells in Transplantation","volume":"10","author":"Zhao","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12967-018-1395-9","article-title":"Myeloid-Derived Suppressor Cells in Transplantation: The Dawn of Cell Therapy","volume":"16","author":"Zhang","year":"2018","journal-title":"J. Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jnc.12135","article-title":"Ly6C+Ly6G- Myeloid-Derived Suppressor Cells Play a Critical Role in the Resolution of Acute Inflammation and the Subsequent Tissue Repair Process after Spinal Cord Injury","volume":"125","author":"Saiwai","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1158\/2159-8290.CD-21-0764","article-title":"Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic","volume":"11","author":"Grover","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-Derived Suppressor Cells: An Emerging Target for Anticancer Immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhang, C., Sui, Y., Liu, S., and Yang, M. (2024). The Roles of Myeloid-Derived Suppressor Cells in Liver. Dis. Biomed., 12.","DOI":"10.3390\/biomedicines12020299"},{"key":"ref_27","first-page":"1912","article-title":"The Protein Kinase Complement of the Human","volume":"298","author":"Manning","year":"2002","journal-title":"Genome Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"Lo The Crucial Role of Protein Phosphorylation in Cell Signalingand Its Use as Targeted Therapy (Review)","volume":"40","author":"Ardito","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s00262-021-02908-5","article-title":"Bruton\u2019s Tyrosine Kinase: An Emerging Targeted Therapy in Myeloid Cells within the Tumor Microenvironment","volume":"70","author":"Good","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"MTOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri3901","article-title":"Regulation of Innate Immune Cell Function by MTOR","volume":"15","author":"Weichhart","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1084\/jem.20161855","article-title":"Critical Roles of MTORC1 Signaling and Metabolic Reprogramming for M-CSF-Mediated Myelopoiesis","volume":"214","author":"Karmaus","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wu, T., Zhao, Y., Wang, H., Li, Y., Shao, L., Wang, R., Lu, J., Yang, Z., Wang, J., and Zhao, Y. (2016). MTOR Masters Monocytic Myeloid-Derived Suppressor Cells in Mice with Allografts or Tumors. Sci. Rep., 6.","DOI":"10.1038\/srep20250"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00262-018-2177-1","article-title":"MTOR-Mediated Glycolysis Contributes to the Enhanced Suppressive Function of Murine Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells","volume":"67","author":"Deng","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a Novel Binding Partner of MTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway That Regulates the Cytoskeleton","volume":"14","author":"Dos","year":"2004","journal-title":"Curr. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41420-021-00568-z","article-title":"IRF-8\/MiR-451a Regulates M-MDSC Differentiation via the AMPK\/MTOR Signal Pathway during Lupus Development","volume":"7","author":"Shi","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","article-title":"Tumor-Induced Tolerance and Immune Suppression Depend on the C\/EBP\u03b2 Transcription Factor","volume":"32","author":"Marigo","year":"2010","journal-title":"Immunity"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.4049\/jimmunol.1402412","article-title":"IFN Regulatory Factor 8 Represses GM-CSF Expression in T Cells To Affect Myeloid Cell Lineage Differentiation","volume":"194","author":"Paschall","year":"2015","journal-title":"J. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1172\/JCI68189","article-title":"Myeloid-Derived Suppressor Cell Development Is Regulated by a STAT\/IRF-8 Axis","volume":"123","author":"Waight","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Moorman, H.R., Reategui, Y., Poschel, D.B., and Liu, K. (2022). IRF8: Mechanism of Action and Health Implications. Cells, 11.","DOI":"10.3390\/cells11172630"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1186\/s12967-023-04772-6","article-title":"The Role of AMPK in Macrophage Metabolism, Function and Polarisation","volume":"21","author":"Cui","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00109-019-01795-9","article-title":"AMPK Activation Inhibits the Functions of Myeloid-Derived Suppressor Cells (MDSC): Impact on Cancer and Aging","volume":"97","author":"Salminen","year":"2019","journal-title":"J. Mol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e1442167","DOI":"10.1080\/2162402X.2018.1442167","article-title":"Metformin Blocks Myeloid-Derived Suppressor Cell Accumulation through AMPK-DACH1-CXCL1 Axis","volume":"7","author":"Qin","year":"2018","journal-title":"OncoImmunology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1158\/0008-5472.CAN-19-0880","article-title":"AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells","volume":"79","author":"Sierra","year":"2019","journal-title":"Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rong, Y., Yuan, C.H., Qu, Z., Zhou, H., Guan, Q., Yang, N., Leng, X.H., Bu, L., Wu, K., and Wang, F.B. (2016). Doxorubicin Resistant Cancer Cells Activate Myeloid-Derived Suppressor Cells by Releasing PGE2. Sci. Rep., 6.","DOI":"10.1038\/srep23824"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Chen, X., Zhang, Z., Bi, Y., Fu, Z., Gong, P., Li, Y., Yu, Q., Jia, A., Wang, J., and Xue, L. (2016). MTOR Signaling Disruption from Myeloid-Derived Suppressive Cells Protects against Immune-Mediated Hepatic Injury through the HIF1\u03b1-Dependent Glycolytic Pathway. J. Leukoc. Biol., 6.","DOI":"10.1189\/jlb.2A1115-492R"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e2695","DOI":"10.1038\/cddis.2017.86","article-title":"The Mtor Signal Regulates Myeloid-Derived Suppressor Cells Differentiation and Immunosuppressive Function in Acute Kidney Injury","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000363719","article-title":"T Lymphocytes and Acute Kidney Injury: Update","volume":"127","author":"Martina","year":"2014","journal-title":"Nephron Clin. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Porta, C., Paglino, C., and Mosca, A. (2014). Targeting PI3K\/Akt\/MTOR Signaling in Cancer. Front. Oncol., 4.","DOI":"10.3389\/fonc.2014.00064"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Xie, S., Chen, M., Yan, B., He, X., Chen, X., and Li, D. (2014). Identification of a Role for the PI3K\/AKT\/MTOR Signaling Pathway in Innate Immune Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094496"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Mafi, S., Mansoori, B., Taeb, S., Sadeghi, H., Abbasi, R., Cho, W.C., and Rostamzadeh, D. (2022). MTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.774103"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"iii70","DOI":"10.1136\/ard.2008.098459","article-title":"The PI3K\/Akt\/MTOR Pathway in Innate Immune Cells: Emerging Therapeutic Applications","volume":"67","author":"Weichhart","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41419-021-04487-w","article-title":"The Downregulation of Type I IFN Signaling in G-MDSCs under Tumor Conditions Promotes Their Development towards an Immunosuppressive Phenotype","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/bloodadvances.2017006858","article-title":"Novel GM-CSF Signals via IFN-GR\/IRF-1 and AKT\/MTOR License Monocytes for Suppressor Function","volume":"1","author":"Ribechini","year":"2017","journal-title":"Blood Adv."},{"key":"ref_55","first-page":"114907","article-title":"Eleutheroside A Inhibits PI3K\/AKT1\/MTOR-Mediated Glycolysis in MDSCs to Alleviate Their Immunosuppressive Function in Gastric Cancer","volume":"159","author":"Jiang","year":"2025","journal-title":"Int. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1002\/eji.200526172","article-title":"Myeloid Dendritic Cell Precursors Generated from Bone Marrow Suppress T Cell Responses via Cell Contact and Nitric Oxide Production in Vitro","volume":"35","author":"Wiethe","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/eji.200939903","article-title":"Hierarchy of Immunosuppressive Strength among Myeloid-Derived Suppressor Cell Subsets Is Determined by GM-CSF","volume":"40","author":"Dolcetti","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Kumar, A., Taghi Khani, A., Sanchez Ortiz, A., and Swaminathan, S. (2022). GM-CSF: A Double-Edged Sword in Cancer Immunotherapy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.901277"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Sun, L., Rautela, J., Delconte, R.B., Souza-Fonseca-Guimaraes, F., Carrington, E.M., Schenk, R.L., Herold, M.J., Huntington, N.D., Lew, A.M., and Xu, Y. (2018). GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01922"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated Regulation of Myeloid Cells by Tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"14208","DOI":"10.1038\/ncomms14208","article-title":"MTORC2 Signalling Regulates M2 Macrophage Differentiation in Response to Helminth Infection and Adaptive Thermogenesis","volume":"8","author":"Hallowell","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.immuni.2016.09.016","article-title":"Metabolic Reprogramming Mediated by the MTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e1146841","DOI":"10.1080\/2162402X.2016.1146841","article-title":"Intratumoral Delivery of MTORC2-Deficient Dendritic Cells Inhibits B16 Melanoma Growth by Promoting CD8+ Effector T Cell Responses","volume":"5","author":"Fabian","year":"2016","journal-title":"OncoImmunology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbalip.2014.12.006","article-title":"PI3K Signalling in Inflammation","volume":"1851","author":"Hawkins","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K Pathway in Human Disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"van Wigcheren, G.F., Cuenca-Escalona, J., Stelloo, S., Brake, J., Peeters, E., Horrevorts, S.K., Fr\u00f6lich, S., Ramos-Tomillero, I., Wesseling-Rozendaal, Y., and van Herpen, C.M.L. (2023). Myeloid-Derived Suppressor Cells and Tolerogenic Dendritic Cells Are Distinctively Induced by PI3K and Wnt Signaling Pathways. J. Biol. Chem., 299.","DOI":"10.1016\/j.jbc.2023.105276"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"27160","DOI":"10.18632\/oncotarget.4746","article-title":"A Core of Kinase-Regulated Interactomes Defines the Neoplastic MDSC Lineage","volume":"6","author":"Zudaire","year":"2015","journal-title":"Oncotarget"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nature21026","article-title":"Erratum: Corrigendum: PI3K\u03b3 Is a Molecular Switch That Controls Immune Suppression","volume":"542","author":"Kaneda","year":"2016","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Wang, W., Xia, X., Mao, L., and Wang, S. (2019). The CCAAT\/Enhancer-Binding Protein Family: Its Roles in MDSC Expansion and Function. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01804"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4049\/jimmunol.171.2.821","article-title":"Functional Cooperation of Simian Virus 40 Promoter Factor 1 and CCAAT\/Enhancer-Binding Protein \u03b2 and \u03b4 in Lipopolysaccharide-Induced Gene Activation of IL-10 in Mouse Macrophages","volume":"171","author":"Liu","year":"2003","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Qi, H., Li, Y., Liu, X., Jiang, Y., Li, Z., Xu, X., Zhang, H., and Hu, X. (2023). Tim-3 Regulates the Immunosuppressive Function of Decidual MDSCs via the FynSTAT3-C\/EBP\u03b2 Pathway during Toxoplasma Gondii Infection. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011329"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1158\/0008-5472.CAN-16-2534","article-title":"Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kd\/G","volume":"77","author":"Davis","year":"2017","journal-title":"Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1158\/0008-5472.CAN-16-1839","article-title":"Differential PI3K\u03b4 Signaling in CD4+ T-Cell Subsets Enables Selective Targeting of t Regulatory Cells to Enhance Cancer Immunotherapy","volume":"77","author":"Ahmad","year":"2017","journal-title":"Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature13444","article-title":"Inactivation of PI(3)K P110\u03b4 Breaks Regulatory T-Cell-Mediated Immune Tolerance to Cancer","volume":"510","author":"Ali","year":"2014","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41416-022-01917-0","article-title":"Treg-Driven Tumour Control by PI3K\u03b4 Inhibition Limits Myeloid-Derived Suppressor Cell Expansion","volume":"127","author":"Lauder","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-immunol-032414-112103","article-title":"TAM Receptor Signaling in Immune Homeostasis","volume":"33","author":"Rothlin","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gutjnl-2016-313615","article-title":"MerTK Expressing Hepatic Macrophages Promote the Resolution of Inflammation in Acute Liver Failure","volume":"67","author":"Triantafyllou","year":"2018","journal-title":"Gut"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"vdaa065","DOI":"10.1093\/noajnl\/vdaa065","article-title":"MerTK Inhibition Decreases Immune Suppressive Glioblastoma-Associated Macrophages and Neoangiogenesis in Glioblastoma Microenvironment","volume":"2","author":"Su","year":"2020","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e179876","DOI":"10.1172\/jci.insight.179876","article-title":"Resolution of Ischemia\/Reperfusion Injury after Lung Transplant MerTK-Dependent Efferocytosis by Monocytic-MDSCs Mediates Resolution of Ischemia\/Reperfusion Injury after Lung Transplant","volume":"9","author":"Leroy","year":"2024","journal-title":"JCI Insight"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/2326-6066.CIR-19-0008","article-title":"TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti\u2013PD-1 Therapy in Melanoma","volume":"7","author":"Holtzhausen","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrc3847","article-title":"The TAM Family: Phosphatidylserine-Sensing Receptor Tyrosine Kinases Gone Awry in Cancer","volume":"14","author":"Graham","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK Signal Pathways in the Regulation of Cell Proliferation in Mammalian Cells","volume":"12","author":"Wei","year":"2002","journal-title":"Cell Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological Roles of MAPK Signaling Pathways in Human Diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1189\/jlb.0209097","article-title":"MAPK Signaling Pathways in the Regulation of Hematopoiesis","volume":"86","author":"Geest","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Yu, J., Li, H., Zhang, Z., Lin, W., Wei, X., and Shao, B. (2021). Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.647312"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Lee, H.J., and Oh, J.Y. (2024). Mesenchymal Stem\/Stromal Cells Induce Myeloid-Derived Suppressor Cells in the Bone Marrow via the Activation of the c-Jun N-Terminal Kinase Signaling Pathway. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202401.0708.v1"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e136059","DOI":"10.1172\/jci.insight.136059","article-title":"Mesenchymal Stromal Cells Induce Distinct Myeloid-Derived Suppressor Cells in Inflammation","volume":"5","author":"Lee","year":"2020","journal-title":"JCI Insight"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1038\/s41467-021-22033-2","article-title":"Immune Suppressive Activity of Myeloid-Derived Suppressor Cells in Cancer Requires Inactivation of the Type I Interferon Pathway","volume":"12","author":"Sanseviero","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41586-022-05575-3","article-title":"An Atlas of Substrate Specificities for the Human Serine\/Threonine Kinome","volume":"613","author":"Johnson","year":"2023","journal-title":"Nature"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e956579","DOI":"10.4161\/21624011.2014.956579","article-title":"Location, Location, Location: Functional and Phenotypic Heterogeneity between Tumor-Infiltrating and Non-Infiltrating Myeloid-Derived Suppressor Cells","volume":"3","author":"Maenhout","year":"2014","journal-title":"OncoImmunology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","article-title":"The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment","volume":"37","author":"Kumar","year":"2016","journal-title":"Trends Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-022-03835-4","article-title":"Endoplasmic Reticulum Stress Mediates the Myeloid-Derived Immune Suppression Associated with Cancer and Infectious Disease","volume":"21","author":"Lou","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.immuni.2020.03.004","article-title":"The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling","volume":"52","author":"Mohamed","year":"2020","journal-title":"Immunity"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e1822","DOI":"10.1038\/cddis.2015.183","article-title":"Protein Kinase R-like ER Kinase and Its Role in Endoplasmic Reticulum Stress-Decided Cell Fate","volume":"6","author":"Liu","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"He, F., Ru, X., and Wen, T. (2020). NRF2, a Transcription Factor for Stress Response and Beyond. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134777"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.4049\/jimmunol.1501785","article-title":"Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2","volume":"196","author":"Beury","year":"2016","journal-title":"J. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Ohl, K., Fragoulis, A., Klemm, P., Baumeister, J., Klock, W., Verjans, E., B\u00f6ll, S., M\u00f6llmann, J., Lehrke, M., and Costa, I. (2018). Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01552"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MOL.0000000000000418","article-title":"Fatty Acid Metabolism Regulates Cell Survival in Specific Niches","volume":"28","author":"Regazzi","year":"2017","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/2326-6066.CIR-20-0433","article-title":"Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer","volume":"9","author":"Xin","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12964-024-01898-y","article-title":"PIM1 Kinase and Its Diverse Substrate in Solid Tumors","volume":"22","author":"Choudhury","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Clements, A.N., and Warfel, N.A. (2022). Targeting PIM Kinases to Improve the Efficacy of Immunotherapy. Cells, 11.","DOI":"10.3390\/cells11223700"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"109160","DOI":"10.1016\/j.celrep.2021.109160","article-title":"Suppressive Neutrophils Require PIM1 for Metabolic Fitness and Survival during Chronic Viral Infection","volume":"35","author":"Volberding","year":"2021","journal-title":"Cell Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e002548","DOI":"10.1136\/jitc-2021-002548","article-title":"S100A4 Enhances Protumor Macrophage Polarization by Control of PPAR-\u00ce 3-Dependent Induction of Fatty Acid Oxidation","volume":"9","author":"Liu","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Tokumitsu, H., and Sakagami, H. (2022). Molecular Mechanisms Underlying Ca2+\/Calmodulin-Dependent Protein Kinase Kinase Signal Transduction. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911025"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1189\/jlb.0311152","article-title":"A Cell-Intrinsic Role for CaMKK2 in Granulocyte Lineage Commitment and Differentiation","volume":"90","author":"Teng","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e3076","DOI":"10.1038\/cddis.2017.474","article-title":"Calcium\/Calmodulin-Dependent Kinase Kinase 2 Regulates Hematopoietic Stem and Progenitor Cell Regeneration","volume":"8","author":"Racioppi","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Huang, W., Liu, Y., Luz, A., Berrong, M., Meyer, J.N., Zou, Y., Swann, E., Sundaramoorthy, P., Kang, Y., and Jauhari, S. (2021). Calcium\/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.754083"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12079-020-00592-1","article-title":"A Complete Map of the Calcium\/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Signaling Pathway","volume":"15","author":"Najar","year":"2020","journal-title":"J. Cell Commun. Signal."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1038\/s41467-022-34175-y","article-title":"Neuronal CaMKK2 Promotes Immunosuppression and Checkpoint Blockade Resistance in Glioblastoma","volume":"13","author":"Tomaszewski","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","article-title":"Molecular Mechanisms Regulating Myeloid-Derived Suppressor Cell Differentiation and Function","volume":"32","author":"Condamine","year":"2011","journal-title":"Trends Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"11579","DOI":"10.1074\/jbc.M111.336032","article-title":"Calcium\/Calmodulin-Dependent Protein Kinase Kinase 2 Regulates Macrophage-Mediated Inflammatory Responses","volume":"287","author":"Racioppi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00018-008-8539-7","article-title":"Therapeutic Protein Kinase Inhibitors","volume":"66","author":"Grant","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc2559","article-title":"Targeting Cancer with Small Molecule Kinase Inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Zaky, M.Y., John, J., Vashisht, M., Singh, P., Al-Hatamleh, M.A.I., Siddoway, K., Chen, Z., and Wang, J.H. (2024). Targeting Myeloid Cells in Head and Neck Squamous Cell Carcinoma: A Kinase Inhibitor Library Screening Approach. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212277"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1172\/JCI76094","article-title":"Targeting Cancer with Kinase Inhibitors","volume":"125","author":"Gross","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2249.2011.04445.x","article-title":"Immunosuppressive Functions of Hepatic Myeloid-Derived Suppressor Cells of Normal Mice and in a Murine Model of Chronic Hepatitis B Virus","volume":"166","author":"Chen","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/00054725-200810001-00040","article-title":"What Is \u201cPhysiological\u201d Intestinal Inflammation and How Does It Differ from \u201cPathological\u201d Inflammation?","volume":"14","author":"Fiocchi","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/PL00000757","article-title":"Regulation of Transcription Factor Function by Phosphorylation","volume":"57","author":"Whitmarsh","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/MCB.00034-14","article-title":"Signal Integration and Gene Induction by a Functionally Distinct STAT3 Phosphoform","volume":"34","author":"Waitkus","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/stem.1609","article-title":"STAT3 Phosphorylation at Tyrosine 705 and Serine 727 Differentially Regulates Mouse Esc Fates","volume":"32","author":"Huang","year":"2013","journal-title":"Stem Cells"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Berkley, K., Zalejski, J., and Sharma, A. (2025). Targeting STAT3 for Cancer Therapy: Focusing on Y705, S727, or Dual Inhibition?. Cancers, 17.","DOI":"10.20944\/preprints202501.1371.v1"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1182\/blood-2009-10-230060","article-title":"STAT3 Is Constitutively Phosphorylated on Serine 727 Residues, Binds DNA, and Activates Transcription in CLL Cells","volume":"115","author":"Harris","year":"2010","journal-title":"Blood"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/14\/6936\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:12:32Z","timestamp":1760033552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/14\/6936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":122,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26146936"],"URL":"https:\/\/doi.org\/10.3390\/ijms26146936","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]}}}